RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
HAVN Life Sciences Stock

HAVN Life Sciences Equity 2025

HAVN Life Sciences Equity

3.14 M CAD

Ticker

HAVN.CN

ISIN

CA4196213058

WKN

A3DR7N

In 2025, HAVN Life Sciences's equity was 3.14 M CAD, a 0% increase from the 0 CAD equity in the previous year.

HAVN Life Sciences Aktienanalyse

What does HAVN Life Sciences do?

HAVN Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing HAVN Life Sciences's Equity

HAVN Life Sciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding HAVN Life Sciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating HAVN Life Sciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

HAVN Life Sciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in HAVN Life Sciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about HAVN Life Sciences stock

What is the equity of HAVN Life Sciences this year?

HAVN Life Sciences has equity of 3.14 M CAD this year.

What was the equity of HAVN Life Sciences compared to the previous year?

The equity of HAVN Life Sciences has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of HAVN Life Sciences?

A high equity is advantageous for investors of HAVN Life Sciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of HAVN Life Sciences?

A low equity can be a risk for investors of HAVN Life Sciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of HAVN Life Sciences affect the company?

An increase in equity of HAVN Life Sciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of HAVN Life Sciences affect the company?

A reduction in equity of HAVN Life Sciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of HAVN Life Sciences?

Some factors that can affect the equity of HAVN Life Sciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of HAVN Life Sciences so important for investors?

The equity of HAVN Life Sciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can HAVN Life Sciences take to change the equity?

To change equity, HAVN Life Sciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does HAVN Life Sciences pay?

Over the past 12 months, HAVN Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, HAVN Life Sciences is expected to pay a dividend of 0 CAD.

What is the dividend yield of HAVN Life Sciences?

The current dividend yield of HAVN Life Sciences is .

When does HAVN Life Sciences pay dividends?

HAVN Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of HAVN Life Sciences?

HAVN Life Sciences paid dividends every year for the past 0 years.

What is the dividend of HAVN Life Sciences?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is HAVN Life Sciences located?

HAVN Life Sciences is assigned to the '-' sector.

Wann musste ich die Aktien von HAVN Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of HAVN Life Sciences from 1/14/2025 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 1/14/2025.

When did HAVN Life Sciences pay the last dividend?

The last dividend was paid out on 1/14/2025.

What was the dividend of HAVN Life Sciences in the year 2024?

In the year 2024, HAVN Life Sciences distributed 0 CAD as dividends.

In which currency does HAVN Life Sciences pay out the dividend?

The dividends of HAVN Life Sciences are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von HAVN Life Sciences

Our stock analysis for HAVN Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HAVN Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.